Store the inhaler with the mouthpiece down ... Trial 3: Clinical Trial with Advair HFA 115 mcg/21 mcg Efficacy results in this trial were similar to those observed in Trials 1 and 2.
The FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory diseases inhaler, after years of delays. Even though Advair’s main patent expired in 2010 and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback